Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT07560865First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
NCT02309944Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
NCT03054909IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
NCT00379197Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT06442384Remote Trial - Tobacco Product Standard (VLNC)
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT00176839Stem Cell Transplantation for Hematological Malignancies
NCT00005987Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
NCT00602693T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT01312818Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT00167167Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00305682Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
NCT03637972COMET2 Project 1 Filter Ventilation Study
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT02206971Biomarker Feedback for Smoking Cessation
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT00265863Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
NCT02361047Let's Play! Healthy Kids After Cancer
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT01009437Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
NCT00262951Chemoradiation in Locally Advanced Pancreatic Cancer
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT00176891Stem Cell Transplant w/Laronidase for Hurler
NCT03651037Physical Activity Platform to Improve Bone Health in Cancer Survivors
NCT02171104MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT04969783Telehealth-Filter Ventilation ( COMET2P1 )
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT01572636Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT00303719Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT00400803Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
NCT00630253Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia